In-Vitro Diagnostic Market
In-Vitro Diagnostic Market Research and Analysis, 2015-2021
Global In vitro diagnostic market is expected to grow at a CAGR of 6% during 2015-2021. Global In-Vitro Diagnostic Market is growing at a modest rate due to technological advancement and R&D in diagnostic devices and test. Rising fatal diseases such as CVD, CHD, Stroke, Cancer and other heart diseases are driving the global In vitro diagnostic market. Investment from government and private players are creating huge scope in global In Vitro Diagnostic Market. Successful clinical trials and rise in patents are boosting the market growth and creating considerable scope in In-Vitro Diagnostic Market. Global In-Vitro Market by applications such as diabetes, infectious diseases, oncology, nephrology, autoimmune diseases and cardiology are generating huge revenues across the globe. In-Vitro Market by end user such as hospitals, laboratory, point of care testing are adopted significantly in developed and emerging economies due to rising life style oriented diseases and improvement in healthcare spending.
Updated version (2019-2025) of the report
is available @ https://www.omrglobal.com/industry-reports/in-vitro-diagnostics-market-size
Global In-Vitro Diagnostic Market by usability includes disposable IVD devices and re-usable IVD devices which are widely adopted across the globe. The Global In-Vitro Diagnostics Market is growing at a steady growth rate due to some other pivotal factors such as FDA clearance to diagnostic devices and successful clinical trials in vitro biomarkers. As a result there are variety of in vitro diagnostic drugs and devices which are used to diagnose and test various fatal diseases across the globe. Global In-Vitro Diagnostics Market products enable the physicians and doctors to diagnose the patient on time and avoid worsening of life style oriented diseases such as CVD, CHD, Cancer, Diabetes and other lingering diseases. Adoption of minimal invasive technologies and their technological advancement are creating huge scope for Global In-Vitro Diagnostics Market. Global In-Vitro Diagnostics Market by products such as Data Management Software/Hardware, Reagents & Kits and Instruments are widely adopted and contributes considerably in the growth of Global In-Vitro Diagnostics Market.
Geographical insights
North America contributes highest in Global In-Vitro Diagnostic Market followed by Europe. The key drivers of the significant contribution of North America is the rising adoption of In-Vitro Diagnostic due to rise in life style oriented diseases such as Cancer, CVD, CHD, Stroke and other heart diseases. Emerging economies such as China, India, Japan and Korea has huge customer base and improved healthcare spending which are expected to create huge opportunity for Global In-Vitro Diagnostic Market. Improved standard of living, infrastructural development and favorable government policies are other factors that are driving the APAC market. The report includes detailed Market Overview, Market Determinants, Company Profiling, Sector Analysis, Market Segmentation, Geographical Analysis, Pipeline Analysis, Patent Analysis, Strategic Recommendations, Key Company Analysis, GAP Analysis, Key Findings, Market Estimations, Market Insights, Analyst Insights and predictive analysis of the market.
Competitive insights
The Key players of Global In-Vitro Diagnostic Market includes: Abbott Laboratories, Inc., Johnson and Johnson, Becton, Dickson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc. Other players contributing considerably to the Global In Vitro Diagnostic Market which includes Bio-Rad Laboratories, Inc., Alere, Inc. Hologic Inc, KEM-EN-TEC Diagnostics Inc, Medtronic, Omega Diagnostics Group, Ortho Clinical Diagnostics, Inc., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Atlas Genetics Ltd., Elitech Group, Biomerieux, Transasia Bio-Medicals, Werfen Group and so on. In-Vitro Diagnostic companies are constantly focusing on R&D, partnerships, product launch, M&A, innovation and technological advancement.
Market segmentation
Global In-Vitro Diagnostic Market is segmented on the basis of application, type, end user, usability and geography. Global In-Vitro Diagnostic Market by application includes diseases such as Cardiology, Oncology, Nephrology, infectious diseases, autoimmune diseases, diabetes and HIV/AIDS. Global In-Vitro Diagnostic Market by application are in huge demand and contributing significantly in generating revenues across the globe. Global In-Vitro Diagnostics Market by end user includes hospitals, laboratories, diagnostic centers, point of care testing and other end users. Emerging economies such as India, China, Japan and Korea are expected to contribute significantly in Global In-Vitro Diagnostic Market due to rising life style oriented diseases and improving healthcare spending. Global In-Vitro Diagnostic Market is segmented on the basis of-
- Global In Vitro Diagnostic Market Research And Analysis, By Application 2015-2021,($ Millions)
- Global In Vitro Diagnostic Market Research And Analysis, By Type 2015-2021, ($ Million)
- Global In Vitro Diagnostic Market Research And Analysis, By End User 2015-2021, ($ Millions)
- Global In Vitro Diagnostic Market Research And Analysis, By Usability 2015-2021, ($ Millions)
- Global In Vitro Diagnostic Market Research And Analysis, By Technology 2015-2021, ($ Millions)
- Global In Vitro Diagnostic Market Research And Analysis, By Region 2015-2021, ($ Millions)
OMR report covers
- Research Methodology
- Market Overview
- Historical data
- Current Market trends
- Regulations
- Market Determinant
- Parent Market Analysis
- Market Segmentation
- Competitive Landscape
- Geographic Analysis
- Company Profiling
- Revenue forecasts
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. REGULATIONS ON MEDICAL DEVICE & DIAGNOSTICS
2.6.1.1.1. UNITED STATES
2.6.1.1.2. EUROPEAN UNION
2.6.1.1.3. CHINA
2.6.1.1.4. INDIA
2.6.2. DRUG & CLINICAL TRIAL REGULATIONS
2.6.2.1.1. UNITED STATES
2.6.2.1.2. EUROPEAN UNION
2.6.2.1.3. CHINA
2.6.2.1.4. INDIA
2.6.2.1.5. REST OF THE WORLD
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. TECHNOLOGICAL ADVANCEMENT AND INNOVATION IN IN VITRO DIAGNOSTICS MARKET
3.1.2. POURING INVESTMENT FROM GOVERNMENT AND PRIVATE PLAYERS TO DRIVE THE MARKET
3.1.3. RISE IN CANCER, CVD, CHD AND OTHER FATAL DISEASES ACROSS THE GLOBE
3.1.4. RESEARCH & DEVELOPMENT AND SUCCESSFUL CLINICAL TRIALS OF IN VITRO DIAGNOSTICS ARE DRIVING THE MARKET
3.1.5. FDA NOD TO IN VITRO DIAGNOSTICS DRUGS ARE BOOSTING THE MARKET
3.1.6. RISE IN ADOPTION OF MINIMAL INVASIVE TECHNOLOGIES
3.1.7. RISE IN HEALTHCARE SPENDING & EXPENDITURE
3.1.8. RISE IN ADOPTION OF PERSONALIZED HEALTHCARE SUCH AS PERSONALIZED MEDICINE & DRUG DISCOVERY AND DEVELOPMENT
3.2. RESTRAINT
3.2.1. HIGH COST OF GLOBAL IN VITRO DIAGNOSTICS TEST & TREATMENT
3.2.2. STRINGENT REIMBURSEMENT POLICIES MAY AFFECT THE GROWTH OF THE MARKET
3.3. OPPORTUNITY
3.3.1. UNTAPPED APAC REGION HAVE HUGE OPPORTUNITY FOR GLOBAL IN VITRO DIAGNOSTICS MARKET
3.3.2. R&D INVESTMENT AND FAVORABLE GOVERNMENT POLICIES ARE DRIVING THE MARKET4
4. PARENT MARKET ANALYSIS
5. MARKET SEGMENTATION
5.1. GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2021,($ MILLIONS)
5.1.1. GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS, 2015-2020, ($ MILLIONS)
5.1.2. GLOBAL INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.3. GLOBAL HIV/AIDS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.4. GLOBAL DRUG TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.5. GLOBAL NEPHROLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.6. GLOBAL AUTOIMMUNE DISEASES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.7. GLOBAL CARDIOLOGY DISEASES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.8. GLOBAL ONCOLOGY/CANCER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.9. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.2. GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2021, ($ MILLIONS)
5.2.1. GLOBAL REAGENTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.2.2. GLOBAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.2.3. GLOBAL HARDWARE DATA MANAGEMENT SYSTEM MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.2.4. GLOBAL SOFTWARE DATA MANAGEMENT SYSTEM MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.2.5. GLOBAL SERVICES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.3. GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY END USER, 2015-2021, ($ MILLIONS)
5.3.1. GLOBAL DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.3.2. GLOBAL POINT OF CARE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.3.3. GLOBAL HOSPITAL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.3.4. GLOBAL LABORATORY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.3.5. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.4. GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY USABILITY, 2015-2021, ($ MILLIONS)
5.4.1. GLOBAL DISPOSABLE IVD DEVICES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.4.2. GLOBAL RE-USABLE IVD DEVICES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5. GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY TECHNOLOGY, 2015-2021, ($ MILLIONS)
5.5.1. GLOBAL CLINICAL CHEMISTRY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.1.1. GLOBAL THYROID FUNCTION PANELS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.1.2. GLOBAL SPECIALTY CHEMICAL TESTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.1.3. GLOBAL BASIC METABOLIC PANEL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.1.4. GLOBAL ELECTROLYTE PANELS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.1.5. GLOBAL RENAL PROFILES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.1.6. GLOBAL LIVER PANELS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.1.7. GLOBAL LIPID PROFILE MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.1.8. GLOBAL OTHERS PROFILE MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.2. GLOBAL IMMUNOCHEMISTRY/IMMUNOASSAYS CHEMISTRY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.2.1. GLOBAL ELISA MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.2.1.1. GLOBAL COLORIMETRIC IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.2.1.2. GLOBAL CHEMILUMINESCENCE IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.2.1.3. GLOBAL COLORIMETRIC IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.2.2. GLOBAL ELISPOT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.2.3. GLOBAL WESTERN BLOT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.2.4. GLOBAL RAPID TESTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.3. GLOBAL HEMATOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.4. GLOBAL COAGULATION AND HEMOSTATIS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.5. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.5.1. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.5.2. GLOBAL DNA SEQUENCING & NEXT-GENERATION SEQUENCING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.5.3. GLOBAL HYBRIDIZATION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.5.4. GLOBAL MICROARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.5.5. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.5.6. GLOBAL OTHER TECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.6. GLOBAL MICROBIOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.5.7. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
6. COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
7. REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
8. COMPANY PROFILES
8.1. ABBOTT LABORATORIES, INC.
8.1.1. INTRODUCTION
8.1.2. ABBOTT LABORATORIES, INC. PRODUCT PORTFOLIO
8.1.3. ABBOTT LABORATORIES, INC. RECENT ACTIVITIES
8.1.4. ABBOTT LABORATORIES, INC. SWOT ANALYSIS
8.2. ALERE INC
8.2.1. INTRODUCTION
8.2.2. ALERE INC PRODUCT PORTFOLIO
8.2.3. ALERE INC RECENT ACTIVITIES
8.2.4. ALERE INC SWOT ANALYSIS
8.3. ATLAS GENETICS LIMITED
8.3.1. INTRODUCTION
8.3.2. ATLAS GENETICS LIMITED PRODUCT PORTFOLIO
8.3.3. ATLAS GENETICS LIMITED RECENT ACTIVITIES
8.3.4. ATLAS GENETICS LIMITED SWOT ANALYSIS
8.4. BECTON, DICKINSON AND COMPANY
8.4.1. INTRODUCTION
8.4.2. BECTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
8.4.3. BECTON, DICKINSON AND COMPANY RECENT ACTIVITIES
8.4.4. BECTON, DICKINSON AND COMPANY SWOT ANALYSIS
8.5. BIOMÉRIEUX
8.5.1. INTRODUCTION
8.5.2. BIOMÉRIEUX PRODUCT PORTFOLIO
8.5.3. BIOMÉRIEUX RECENT ACTIVITIES
8.5.4. BIOMÉRIEUX SWOT ANALYSIS
8.6. BIO-RAD LABORATORIES, INC.
8.6.1. INTRODUCTION
8.6.2. BIO-RAD LABORATORIES, INC. PRODUCT PORTFOLIO
8.6.3. BIO-RAD LABORATORIES, INC. RECENT ACTIVITIES
8.6.4. BIO-RAD LABORATORIES, INC. SWOT ANALYSIS
8.7. DANAHER CORPORATION
8.7.1. INTRODUCTION
8.7.2. DANAHER CORPORATION PRODUCT PORTFOLIO
8.7.3. DANAHER CORPORATION RECENT ACTIVITIES
8.7.4. DANAHER CORPORATION SWOT ANALYSIS
8.8. ELITECH GROUP
8.8.1. INTRODUCTION
8.8.2. ELITECH GROUP PRODUCT PORTFOLIO
8.8.3. ELITECH GROUP RECENT ACTIVITIES
8.8.4. ELITECH GROUP SWOT ANALYSIS
8.9. ELITECH GROUP
8.9.1. INTRODUCTION
8.9.2. ELITECH GROUP PRODUCT PORTFOLIO
8.9.3. ELITECH GROUP RECENT ACTIVITIES
8.9.4. ELITECH GROUP SWOT ANALYSIS
8.10. JOHNSON & JOHNSON
8.10.1. INTRODUCTION
8.10.2. JOHNSON & JOHNSON PRODUCT PORTFOLIO
8.10.3. JOHNSON & JOHNSON RECENT ACTIVITIES
8.10.4. JOHNSON & JOHNSON SWOT ANALYSIS
8.11. KEM-EN-TEC DIAGNOSTICS INC
8.11.1. INTRODUCTION
8.11.2. KEM-EN-TEC DIAGNOSTICS INC PRODUCT PORTFOLIO
8.11.3. KEM-EN-TEC DIAGNOSTICS INC RECENT ACTIVITIES
8.11.4. KEM-EN-TEC DIAGNOSTICS INC SWOT ANALYSIS
8.12. MEDTRONIC
8.12.1. INTRODUCTION
8.12.2. MEDTRONIC PRODUCT PORTFOLIO
8.12.3. MEDTRONIC RECENT ACTIVITIES
8.12.4. MEDTRONIC SWOT ANALYSIS
8.13. OMEGA DIAGNOSTICS GROUP
8.13.1. INTRODUCTION
8.13.2. OMEGA DIAGNOSTICS GROUP PRODUCT PORTFOLIO
8.13.3. OMEGA DIAGNOSTICS GROUP RECENT ACTIVITIES
8.13.4. OMEGA DIAGNOSTICS GROUP SWOT ANALYSIS
8.14. ORTHO CLINICAL DIAGNOSTICS, INC.
8.14.1. INTRODUCTION
8.14.2. ORTHO CLINICAL DIAGNOSTICS, INC. PRODUCT PORTFOLIO
8.14.3. ORTHO CLINICAL DIAGNOSTICS, INC. RECENT ACTIVITIES
8.14.4. ORTHO CLINICAL DIAGNOSTICS, INC. SWOT ANALYSIS
8.15. ROCHE DIAGNOSTICS
8.15.1. INTRODUCTION
8.15.2. ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
8.15.3. ROCHE DIAGNOSTICS RECENT ACTIVITIES
8.15.4. ROCHE DIAGNOSTICS SWOT ANALYSIS
8.16. SIEMENS HEALTHCARE
8.16.1. INTRODUCTION
8.16.2. SIEMENS HEALTHCARE PRODUCT PORTFOLIO
8.16.3. SIEMENS HEALTHCARE RECENT ACTIVITIES
8.16.4. SIEMENS HEALTHCARE SWOT ANALYSIS
8.17. SYSMEX CORPORATION
8.17.1. INTRODUCTION
8.17.2. SYSMEX CORPORATION PRODUCT PORTFOLIO
8.17.3. SYSMEX CORPORATION RECENT ACTIVITIES
8.17.4. SYSMEX CORPORATION SWOT ANALYSIS
8.18. THERMO FISHER SCIENTIFIC, INC.
8.18.1. INTRODUCTION
8.18.2. THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
8.18.3. THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
8.18.4. THERMO FISHER SCIENTIFIC, INC. SWOT ANALYSIS
8.19. TRANSASIA BIO-MEDICALS
8.19.1. INTRODUCTION
8.19.2. TRANSASIA BIO-MEDICALS PRODUCT PORTFOLIO
8.19.3. TRANSASIA BIO-MEDICALS RECENT ACTIVITIES
8.19.4. TRANSASIA BIO-MEDICALS SWOT ANALYSIS
8.20. WERFEN GROUP
8.20.1. INTRODUCTION
8.20.2. WERFEN GROUP PRODUCT PORTFOLIO
8.20.3. WERFEN GROUP RECENT ACTIVITIES
8.20.4. WERFEN GROUP SWOT ANALYSIS
TABLE # 1 GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2021, ($ MILLIONS)
TABLE # 2 GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS, 2015-2020, ($ MILLIONS)
TABLE # 3 GLOBAL INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 4 GLOBAL HIV/AIDS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 5 GLOBAL DRUG TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 6 GLOBAL NEPHROLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 7 GLOBAL AUTOIMMUNE DISEASES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 8 GLOBAL CARDIOLOGY DISEASES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 9 GLOBAL ONCOLOGY/CANCER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 10 GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 11 GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2021, ($ MILLIONS)
TABLE # 12 GLOBAL REAGENTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 13 GLOBAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 14 GLOBAL HARDWARE DATA MANAGEMENT SYSTEM MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 15 GLOBAL SOFTWARE DATA MANAGEMENT SYSTEM MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 16 GLOBAL SERVICES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 17 GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY END USER, 2015-2021, ($ MILLIONS)
TABLE # 18 GLOBAL DIAGNOSTIC CENTRES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 19 GLOBAL POINT OF CARE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 20 GLOBAL HOSPITAL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 21 GLOBAL LABORATORY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 22 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 23 GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY USABILITY, 2015-2021, ($ MILLIONS)
TABLE # 24 GLOBAL DISPOSABLE IVD DEVICES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 25 GLOBAL RE-USABLE IVD DEVICES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 26 GLOBAL IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY TECHNOLOGY, 2015-2021, ($ MILLIONS)
TABLE # 27 GLOBAL CLINICAL CHEMISTRY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 28 GLOBAL THYROID FUNCTION PANELS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 29 GLOBAL SPECIALTY CHEMICAL TESTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 30 GLOBAL BASIC METABOLIC PANEL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 31 GLOBAL ELECTROLYTE PANELS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 32 GLOBAL RENAL PROFILES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 33 GLOBAL LIVER PANELS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 34 GLOBAL LIPID PROFILE MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 35 GLOBAL OTHERS PROFILE MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 36 GLOBAL IMMUNOCHEMISTRY/IMMUNOASSAYS CHEMISTRY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 37 GLOBAL ELISA MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 38 GLOBAL COLORIMETRIC IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 39 GLOBAL CHEMILUMINESCENCE IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 40 GLOBAL COLORIMETRIC IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 41 GLOBAL ELISPOT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 42 GLOBAL WESTERN BLOT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 43 GLOBAL RAPID TESTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 44 GLOBAL HEMATOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 45 GLOBAL COAGULATION AND HEMOSTATIS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 46 GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 47 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 48 GLOBAL DNA SEQUENCING & NEXT-GENERATION SEQUENCING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 49 GLOBAL HYBRIDIZATION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 50 GLOBAL MICROARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 51 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 52 GLOBAL OTHER TECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 53 GLOBAL MICROBIOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 54 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 55 ABBOTT LABORATORIES, INC. PRODUCT PORTFOLIO
TABLE # 56 ABBOTT LABORATORIES, INC. RECENT ACTIVITIES
TABLE # 57 ABBOTT LABORATORIES, INC. SWOT ANALYSIS
TABLE # 58 ALERE INC PRODUCT PORTFOLIO
TABLE # 59 ALERE INC RECENT ACTIVITIES
TABLE # 60 ALERE INC SWOT ANALYSIS
TABLE # 61 ATLAS GENETICS LIMITED PRODUCT PORTFOLIO
TABLE # 62 ATLAS GENETICS LIMITED RECENT ACTIVITIES
TABLE # 63 ATLAS GENETICS LIMITED SWOT ANALYSIS
TABLE # 64 BECTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
TABLE # 65 BECTON, DICKINSON AND COMPANY RECENT ACTIVITIES
TABLE # 66 BECTON, DICKINSON AND COMPANY SWOT ANALYSIS
TABLE # 67 BIOMÉRIEUX PRODUCT PORTFOLIO
TABLE # 68 BIOMÉRIEUX RECENT ACTIVITIES
TABLE # 69 BIOMÉRIEUX SWOT ANALYSIS
TABLE # 70 BIO-RAD LABORATORIES, INC. PRODUCT PORTFOLIO
TABLE # 71 BIO-RAD LABORATORIES, INC. RECENT ACTIVITIES
TABLE # 72 BIO-RAD LABORATORIES, INC. SWOT ANALYSIS
TABLE # 73 DANAHER CORPORATION PRODUCT PORTFOLIO
TABLE # 74 DANAHER CORPORATION RECENT ACTIVITIES
TABLE # 75 DANAHER CORPORATION SWOT ANALYSIS
TABLE # 76 ELITECH GROUP PRODUCT PORTFOLIO
TABLE # 77 ELITECH GROUP RECENT ACTIVITIES
TABLE # 78 ELITECH GROUP SWOT ANALYSIS
TABLE # 79 ELITECH GROUP PRODUCT PORTFOLIO
TABLE # 80 ELITECH GROUP RECENT ACTIVITIES
TABLE # 81 ELITECH GROUP SWOT ANALYSIS
TABLE # 82 JOHNSON & JOHNSON PRODUCT PORTFOLIO
TABLE # 83 JOHNSON & JOHNSON RECENT ACTIVITIES
TABLE # 84 JOHNSON & JOHNSON SWOT ANALYSIS
TABLE # 85 KEM-EN-TEC DIAGNOSTICS INC PRODUCT PORTFOLIO
TABLE # 86 KEM-EN-TEC DIAGNOSTICS INC RECENT ACTIVITIES
TABLE # 87 KEM-EN-TEC DIAGNOSTICS INC SWOT ANALYSIS
TABLE # 88 MEDTRONIC PRODUCT PORTFOLIO
TABLE # 89 MEDTRONIC RECENT ACTIVITIES
TABLE # 90 MEDTRONIC SWOT ANALYSIS
TABLE # 91 OMEGA DIAGNOSTICS GROUP PRODUCT PORTFOLIO
TABLE # 92 OMEGA DIAGNOSTICS GROUP RECENT ACTIVITIES
TABLE # 93 OMEGA DIAGNOSTICS GROUP SWOT ANALYSIS
TABLE # 94 ORTHO CLINICAL DIAGNOSTICS, INC. PRODUCT PORTFOLIO
TABLE # 95 ORTHO CLINICAL DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE # 96 ORTHO CLINICAL DIAGNOSTICS, INC. SWOT ANALYSIS
TABLE # 97 ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
TABLE # 98 ROCHE DIAGNOSTICS RECENT ACTIVITIES
TABLE # 99 ROCHE DIAGNOSTICS SWOT ANALYSIS
TABLE # 100 SIEMENS HEALTHCARE PRODUCT PORTFOLIO
TABLE # 101 SIEMENS HEALTHCARE RECENT ACTIVITIES
TABLE # 102 SIEMENS HEALTHCARE SWOT ANALYSIS
TABLE # 103 SYSMEX CORPORATION PRODUCT PORTFOLIO
TABLE # 104 SYSMEX CORPORATION RECENT ACTIVITIES
TABLE # 105 SYSMEX CORPORATION SWOT ANALYSIS
TABLE # 106 THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
TABLE # 107 THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
TABLE # 108 THERMO FISHER SCIENTIFIC, INC. SWOT ANALYSIS
TABLE # 109 TRANSASIA BIO-MEDICALS PRODUCT PORTFOLIO
TABLE # 110 TRANSASIA BIO-MEDICALS RECENT ACTIVITIES
TABLE # 111 TRANSASIA BIO-MEDICALS SWOT ANALYSIS
TABLE # 112 WERFEN GROUP PRODUCT PORTFOLIO
TABLE # 113 WERFEN GROUP RECENT ACTIVITIES
TABLE # 114 WERFEN GROUP SWOT ANALYSIS
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
